Alliancebernstein L.P. Bicycle Therapeutics PLC Transaction History

Alliancebernstein L.P.

  • $287 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$20.37 - $32.9 $185,591 - $299,751
9,111 Added 14.36%
72,549 $2.15 Million
Q3 2022

Nov 15, 2022
SELL
$17.49 - $28.44 $1.2 Million - $1.96 Million
-68,868 Reduced 52.05%
63,438 $1.48 Million
Q2 2022

Aug 15, 2022
BUY
$12.95 - $46.99 $1.71 Million - $6.22 Million
132,306 New
132,306 $2.22 Million

Others Institutions Holding BCYC

# of Institutions
112
Shares Held
41.2M
Call Options Held
39.6K
Put Options Held
24.6K
View Full List

About BICYCLE THERAPEUTICS plc

BCYC Quotes by TradingView
  • Ticker BCYC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,676,100
  • Market Cap $607M
  • Description
  • Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...
More about BCYC
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email